End Stage Kidney Disease
End Stage Kidney Disease (ESKD) is a serious condition where the kidneys have lost most of their function, requiring dialysis or a kidney transplant to manage waste and fluid in the body.
Chronic Dialysis: Patiromer for Potassium Management
We are studying whether patiromer can help patients on chronic dialysis eat more potassium-rich foods safely. This trial looks at its impact on health-related quality of life and dietary restrictions.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Are you currently on dialysis three times a week for at least three months?
- Is your potassium level between 4.0 and 5.5 mEq/L?
- Are you pregnant, breastfeeding, or planning to become pregnant in the next 90 days?
- Are you taking potassium-sparing diuretics like Spironolactone or Eplerenone?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Veltassa
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Azienda Socio Sanitaria Territoriale Della Valle Olona
SC Nefrologia e Dialisi
Busto Arsizio, Italy
Azienda Socio Sanitaria Territoriale Nord Milano
SC Nefrologia e Dialisi
Cinisello Balsamo, Italy
Azienda Socio Sanitaria Territoriale Nord Milano
SC Nefrologia e Dialisi
Sesto San Giovanni, Italy
Sponsor: Istituto Di Ricerche Farmacologiche Mario Negri
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.